INS and COVID-19: A more severe progression of COVID-19 described in patients who develop sustained hyperglycemia at the beginning of the infection, even in individuals without diabetes, were related to the systemic inflammation, insulin resistance and its vascular consequences, usually observed in individuals with diabetes or metabolic syndrome [6, 16].